SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Rigetti Computing, Inc. provides full-stack quantum computing services. It serves global enterprise, government, and research clients through its Rigetti Quantum Cloud Services platform. The company was founded by Chad Rigetti in 2013 and is headquartered in Berkeley, CA.

Rigetti Computing Inc

Rigetti Computing is trending due to increased interest in quantum computing stocks, spurred by news of a substantial investment in quantum technologies. The community is actively discussing the potential for a short squeeze and comparing RGTI to other quantum and AI-related stocks. High trading volume and positive market sentiment are contributing to the stock's upward momentum.

Q/C Technologies, Inc. operates as a clinical-stage pharmaceutical company, which engages in the development of drug products to extend healthy lifespan. It focuses on developing two novel therapeutic platforms, MyMD-1 and SUPERA-CBD, which aim to treat the causes of disease rather than just addressing the symptoms. MyMD-1 is a clinical-stage small molecule that regulates the immune system to control TNF-a, which drives chronic inflammation, and other pro-inflammatory cytokines. SUPERA-CBD is a synthetic derivative of cannabidiol being developed to treat conditions such as epilepsy, chronic pain, depression, as well as neuroinflammatory and neurodegenerative diseases. The company was founded in 1989 and is headquartered in New York, NY.

Q/C Technologies Inc.

QCLS is trending due to its strategic shift towards quantum computing with potential applications in energy-efficient blockchain and cryptocurrency, drawing attention from investors. The community is actively discussing the implications of their laser-based processing unit (LPU) technology and its potential to disrupt the crypto and AI industries. Traders are also watching for news and potential partnerships related to its low float and threshold list status.

D-Wave Quantum, Inc. engages in the development and delivery of quantum computing systems, software, and services. It provides customers with access to the company’s quantum computing systems via the cloud in the form of quantum computing as a service. It offers professional services such as customer assistance in identifying and implementing quantum-computing applications. The company was founded on January 25, 2022 and is headquartered in Palo Alto, CA.

D-Wave Quantum Inc

QBTS is trending as part of a broader surge in quantum computing stocks, driven by increasing interest and speculation around government contracts and potential big tech partnerships. Community discussions revolve around the company's valuation, short squeeze potential, and its competitive position relative to other quantum firms like RGTI and IONQ. Some investors express concerns about a potential bubble, while others highlight D-Wave's technological advantages and growing real-world applications.

Apple, Inc. engages in the design, manufacture, and sale of smartphones, personal computers, tablets, wearables and accessories, and other varieties of related services. It operates through the following geographical segments: Americas, Europe, Greater China, Japan, and Rest of Asia Pacific. The Americas segment includes North and South America. The Europe segment consists of European countries, as well as India, the Middle East, and Africa. The Greater China segment comprises China, Hong Kong, and Taiwan. The Rest of Asia Pacific segment includes Australia and Asian countries. Its products and services include iPhone, Mac, iPad, AirPods, Apple TV, Apple Watch, Beats products, AppleCare, iCloud, digital content stores, streaming, and licensing services. The company was founded by Steven Paul Jobs, Ronald Gerald Wayne, and Stephen G. Wozniak in April 1976 and is headquartered in Cupertino, CA.

Apple Inc

AAPL is trending due to a mixed analyst outlook, highlighted by Jefferies downgrading the stock to Underperform while Morgan Stanley raised its price target significantly, sparking debate among investors about the company's valuation and future performance. The community is actively discussing the credibility of these differing analyses and their potential impact on Apple's stock price, while also eyeing potential upside catalysts such as strong iPhone 17 sales and long-term bullish positioning by institutions.

Rumble, Inc. engages in operating an online neutral video platform. It operates through the following geographical segments: United States, Canada, and Other. The company was founded in October 2013 by Chris Pavlovski and is headquartered in Longboat Key, FL.

Rumble Inc - Ordinary Shares - Class A

Rumble Inc

Rumble is trending following the announcement of a partnership with AI search engine Perplexity, aimed at enhancing video discovery on the platform. The community is buzzing about the potential impact of this collaboration, especially regarding AI-driven content recommendations and a new subscription bundle. Some traders speculate about a possible short squeeze, referencing the high short interest and significant call option activity.

Quantum Computing, Inc. engages in developing novel algorithms and solutions utilizing quantum and quantum-inspired computing to solve difficult problems in various industries. It leverages its expertise in finance, computing, security, mathematics, and physics to develop commercial applications for the financial, security, and government sectors. The company was founded on July 25, 2001 and is headquartered in Hoboken, NJ.

Quantum Computing Inc

QUBT is trending due to a planned $500 million private placement, sparking discussions about dilution and the company's growth prospects. Community members are debating the stock's valuation relative to its revenue and comparing it to other quantum computing stocks like IONQ and RGTI. Some traders are optimistic about the future of quantum computing and government support, while others express skepticism and highlight potential risks.

IonQ, Inc. develops and manufactures quantum computers. The firm specializes in quantum computing and quantum information processing. The company was founded by Christopher Monroe and Jung Sang Kim in 2015 and is headquartered in College Park, MD.

IonQ Inc

IONQ is trending as investors weigh its potential in the quantum computing sector against concerns of profitability and valuation. Community discussions involve comparisons to other quantum stocks like QBTS and RGTI, with some highlighting IONQ's partnerships and technological advancements. Bullish sentiment appears to be fueled by potential short squeezes and the expectation of government funding.

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980, and is headquartered in Cambridge, MA.

Sarepta Therapeutics Inc

Sarepta Therapeutics is trending due to anticipation surrounding multiple data presentations at an upcoming conference, sparking optimism within the community. Investors are discussing the potential impact of these results, particularly on the company's pipeline and market position. Some are speculating about potential M&A activity, while others focus on the potential for a significant price increase based on positive data and the company's overall value.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is trending as investors discuss the implications of an upcoming warrant distribution and a mixed securities shelf offering. The community is split, with some viewing the warrant as a positive catalyst for a potential squeeze, while others express concern about possible dilution and the actions of company leadership. The stock's volatile price action and potential for manipulation are also key discussion points.

GSR III Acquisition Corp engages in the merger, share exchange, asset acquisition, share purchase or reorganization with one or more businesses. The company was founded on May 10, 2023 and is headquartered in Austin, Texas.

GSR III Acquisition Corp. - Ordinary Shares- Class A

GSR III Acquisition Corp. Ordinary Shares

GSRT is trending due to its upcoming merger with Terra Innovatum, a nuclear energy company, generating community discussion about the potential of the micro-modular reactor technology and comparison to sector peers. Community members are weighing the risks and potential rewards associated with holding through the merger and ticker change, while also considering the broader context of renewed interest in nuclear energy. Some traders point to unusual options activity and analyst coverage as potential catalysts.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Don't Overlook These 2 Highly Ranked Medical Stocks: COLL, MASI

Two medical sector stocks are standing out among the recent additions to the Zacks Rank #1 (Strong Buy) list in Collegium Pharmaceutical (COLL) and Masimo Corporation (MASI). 

All You Need to Know About Collegium Pharmaceutical (COLL) Rating Upgrade to Strong Buy

Collegium Pharmaceutical (COLL) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Are Medical Stocks Lagging  Argenx (ARGX) This Year?

Here is how argenex SE (ARGX) and Collegium Pharmaceutical (COLL) have performed compared to their sector so far this year.

Should Value Investors Buy Collegium Pharmaceutical (COLL) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Compared to Estimates, Collegium Pharmaceutical (COLL) Q2 Earnings: A Look at Key Metrics

Although the revenue and EPS for Collegium Pharmaceutical (COLL) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Collegium Pharmaceutical (COLL) Q2 Earnings and Revenues Surpass Estimates

Collegium Pharmaceutical (COLL) delivered earnings and revenue surprises of +3.70% and +4.23%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Inotiv, Inc. (NOTV) Reports Q3 Loss, Tops Revenue Estimates

Inotiv (NOTV) delivered earnings and revenue surprises of +20.00% and +4.94%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Zevra Therapeutics (ZVRA) Reports Next Week: Wall Street Expects Earnings Growth

Zevra Therapeutics (ZVRA) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Collegium Pharmaceutical (COLL) Q2 Earnings Preview: What's in the Cards?

Collegium Pharmaceutical (COLL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Wall Street Analysts See a 33.91% Upside in Collegium Pharmaceutical (COLL): Can the Stock Really Move This High?

The consensus price target hints at a 33.9% upside potential for Collegium Pharmaceutical (COLL). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Collegium Pharmaceutical, Inc. is a pharmaceutical company, which engages in development and planning to commercialize next generation, abuse-deterrent products for the treatment of patients suffering from chronic pain and other diseases. Its products include Xtampza ER, Nucynta ER and Nucynta IR, Belbuca, and Symproic. The company was founded by Michael Thomas Heffernan in April 2002 and is headquartered in Stoughton, MA.

Collegium Pharmaceutical Inc

0 to 25,000

25,000 to 50,000

50,000 to 75,000

75,000 to 100,000

How many jobs did the U.S. add in September? Vote below + drop your exact prediction in the comments. 
 
*Powered by Polymarket

COLL
Collegium Pharmaceutical Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest COLL News

COLL Collegium Pharmaceutical Inc